HPV Vaccine Associated with Substantial Decrease in Male Head and Neck Cancers

A new observational study in the US indicates that the HPV vaccine is associated with a nearly 70% reduction in head and neck cancers, particularly oropharyngeal squamous cell carcinoma, among vaccinated men. This finding reinforces the vaccine's established success in preventing cervical cancer and highlights its broader public health benefits for both sexes, following FDA expansion in 2020.